Management of Hyperkalemia in Elderly Diabetic Patients

Immediate Actions

The European Society of Cardiology recommends stopping losartan immediately and monitoring potassium levels within 2-4 days, as the ARB is the primary cause of hyperkalemia and should be avoided when serum potassium exceeds 5.5 mmol/L 1, 2
Continue hydrochlorothiazide 25 mg daily, as thiazide diuretics promote potassium excretion and will help correct the hyperkalemia 1, 2
Recheck serum potassium, renal function, and electrolytes within 2-4 days after stopping losartan 1, 2

The European Society of Cardiology recommends continuing hydrochlorothiazide 25 mg daily as monotherapy initially, as thiazide-ARB combinations are preferred evidence-based regimens, but the ARB must be discontinued due to hyperkalemia 3, 4
Add a calcium channel blocker (amlodipine or another dihydropyridine) as the next step, since calcium antagonist plus thiazide diuretic is a well-tolerated, effective combination in elderly patients 3, 4

Recheck potassium, creatinine, BUN, and sodium on days 2-4, and repeat electrolytes and renal function if initial values show improvement 1, 2
Monitor potassium and renal function every 3-6 months in elderly diabetic patients on diuretics 1, 2

Never continue losartan with potassium >5.5 mEq/L, as this significantly increases risk of life-threatening hyperkalemia and cardiac arrhythmias 1, 2
Do not add potassium-sparing diuretics (spironolactone, amiloride, triamterene) in elderly diabetics with baseline hyperkalemia, as this dramatically increases hyperkalemia risk 1, 2, 5
Avoid restarting ARB/ACE inhibitor too quickly before confirming potassium normalization and stable renal function 1, 2
Do not use beta-blockers as the next add-on agent in diabetic patients, as the combination of thiazide plus beta-blocker has pronounced dysmetabolic effects and increases risk of new-onset diabetes 3, 4